Our History
Since our founding in 2018, BioGenesis has been at the forefront of nucleic acid therapeutics and protein engineering innovation.
2018
Company Founded
BioGenesis was established in Shanghai with a mission to advance nucleic acid therapeutics.
2019
First mRNA Product Launch
Launched our first commercial mRNA synthesis service for research customers.
2020
Series A Funding
Closed Series A funding of $20M to expand R&D capabilities and team.
2021
siRNA Platform Launch
Introduced our AI-powered siRNA design and screening platform.
2022
GMP Facility Certified
Achieved GMP certification for our nucleic acid manufacturing facility.
2024
New R&D Center
Opened new 5,000 sqm R&D laboratory in Shanghai Zhangjiang Hi-Tech Park.